Filing Details
- Accession Number:
- 0001209191-17-047736
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-04 16:53:11
- Reporting Period:
- 2017-08-03
- Filing Date:
- 2017-08-04
- Accepted Time:
- 2017-08-04 16:53:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1557290 | A Stuart Arbuckle | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp\Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-08-03 | 4,250 | $109.14 | 125,367 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-08-03 | 4,250 | $155.72 | 121,117 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-08-03 | 4,250 | $0.00 | 4,250 | $109.14 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 25,500 | 2025-02-02 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1.
- The option vests in 16 quarterly installments from 2/3/2015.
Billionaire Hedge Funds
